2024/03/04 Press Release
Biotube Co., Ltd. became the subsidiary of EPS Innovative Medicine (Japan) Co., Ltd.
A group company of EPS Creative Health Technology Group Ltd.（HKEX：3860，Executive Director/CEO Tatsuji Shimada, MBA, hereinafter “EPS CHT”), EPS Innovative Medicine (Japan) Co., Ltd. (Representative Director: Tomohiro Nakatani) announced that on January 29, 2024, it acquired shares of Biotube Co., Ltd. (Representative Director: Yasuhide Nakayama, PhD, hereinafter “Biotube”), which is developing medical devices specialized in iBTA technology*1, making Biotube a consolidated subsidiary. EPS CHT intends to create synergies by making Biotube a member of the group company and also to commercialize medical devices.
Biotube Co Ltd became the subsidiary of EPS Innovative Medicine (Japan) Co Ltd